US Patent 11261151 Methods for making and using endoxifen
Patent 11261151 was granted and assigned to Atossa Therapeutics, Inc. on March, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11261151 Methods for making and using endoxifen
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
